Niclas C. Blessin

822 total citations
16 papers, 28 citations indexed

About

Niclas C. Blessin is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Niclas C. Blessin has authored 16 papers receiving a total of 28 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Niclas C. Blessin's work include Cancer Immunotherapy and Biomarkers (7 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Niclas C. Blessin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Niclas C. Blessin collaborates with scholars based in Germany and Poland. Niclas C. Blessin's co-authors include Guido Sauter, Claudia Hube‐Magg, Till S. Clauditz, Tim Mandelkow, Martina Kluth, Sören Weidemann, Roland Dahlem, Maximilian Lennartz, Till Eichenauer and Franziska Büscheck and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Niclas C. Blessin

11 papers receiving 26 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niclas C. Blessin Germany 3 16 13 12 7 5 16 28
Paul Farrington United Kingdom 3 27 1.7× 30 2.3× 16 1.3× 7 1.0× 4 0.8× 4 51
Taweevat Attaseth Thailand 3 15 0.9× 21 1.6× 5 0.4× 9 1.3× 6 1.2× 3 42
Jaya Thomas United Kingdom 3 9 0.6× 23 1.8× 17 1.4× 6 0.9× 6 1.2× 6 38
Ani K. Stoyanova Germany 3 25 1.6× 12 0.9× 15 1.3× 6 0.9× 6 1.2× 6 45
Katsushige Kawase Japan 3 14 0.9× 14 1.1× 13 1.1× 5 0.7× 2 0.4× 6 32
Nelusha Amaladas United States 4 25 1.6× 28 2.2× 14 1.2× 10 1.4× 7 1.4× 7 48
Yuxin Huang China 4 17 1.1× 10 0.8× 9 0.8× 4 0.6× 3 0.6× 11 44
Maryam Bourhaba Belgium 3 14 0.9× 12 0.9× 4 0.3× 10 1.4× 4 0.8× 10 33
Xinru Lim Singapore 3 12 0.8× 25 1.9× 20 1.7× 6 0.9× 3 0.6× 7 56

Countries citing papers authored by Niclas C. Blessin

Since Specialization
Citations

This map shows the geographic impact of Niclas C. Blessin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niclas C. Blessin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niclas C. Blessin more than expected).

Fields of papers citing papers by Niclas C. Blessin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niclas C. Blessin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niclas C. Blessin. The network helps show where Niclas C. Blessin may publish in the future.

Co-authorship network of co-authors of Niclas C. Blessin

This figure shows the co-authorship network connecting the top 25 collaborators of Niclas C. Blessin. A scholar is included among the top collaborators of Niclas C. Blessin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niclas C. Blessin. Niclas C. Blessin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lennartz, Maximilian, Niclas C. Blessin, Simon Kind, et al.. (2023). 2355P Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors. Annals of Oncology. 34. S1197–S1197. 1 indexed citations
2.
Klatte, Tobias, Sefer Elezkurtaj, Maria De Santis, et al.. (2023). Presence of CD8+ cytotoxic T-cells in proximity to tumor cells, TIM3, CTLA-4 and prognostic implications for muscle-invasive urothelial cancer.. Journal of Clinical Oncology. 41(16_suppl). 4582–4582. 1 indexed citations
3.
Kluth, Martina, Maximilian Lennartz, Niclas C. Blessin, et al.. (2023). MYC amplifications are a common event in urothelial bladder carcinomas associated with an aggressive tumor phenotype. American Journal of Clinical Pathology. 160(Supplement_1). S91–S92. 1 indexed citations
4.
Mandelkow, Tim, Guido Sauter, Niclas C. Blessin, et al.. (2023). Intraepithelial CD8+ cytotoxic T-cells are the main component of the immune tumor microenvironment that drive prognosis in muscle-invasive bladder cancer. American Journal of Clinical Pathology. 160(Supplement_1). S45–S46.
5.
Lennartz, Maximilian, Niclas C. Blessin, Claudia Hube‐Magg, et al.. (2023). TRPS1 is a highly sensitive marker for breast cancer: A tissue microarray study evaluating more than 19,000 tumors from 152 different tumor entities. American Journal of Clinical Pathology. 160(Supplement_1). S12–S13. 2 indexed citations
6.
Lennartz, Maximilian, Niclas C. Blessin, Simon Kind, et al.. (2023). Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors. American Journal of Clinical Pathology. 160(Supplement_1). S36–S36. 1 indexed citations
7.
Möller, Katharina, Natalia Gorbokon, Claudia Hube‐Magg, et al.. (2023). Comparison of INSM1 immunostaining with established neuroendocrine markers Synaptophysin and Chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors. American Journal of Clinical Pathology. 160(Supplement_1). S36–S37.
8.
Lennartz, Maximilian, Niclas C. Blessin, Simon Kind, et al.. (2023). Carcinoembryonic antigen (CEA) expression in human tumors: A tissue microarray study on 15,413 tumors.. Journal of Clinical Oncology. 41(16_suppl). e15181–e15181. 2 indexed citations
9.
Burandt, Eike, Niclas C. Blessin, Florian Lutz, et al.. (2022). T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer. Cancers. 14(17). 4246–4246. 3 indexed citations
10.
Möller, Katharina, Tim Mandelkow, Ronald Simon, et al.. (2022). Abstract 597: BLEACH&STAIN 15 marker multiplexed imaging in 3098 human carcinomas revealed six major PD-L1 driven immune phenotypes with distinct spatial orchestration. Cancer Research. 82(12_Supplement). 597–597. 1 indexed citations
11.
Uzunoǧlu, Faik G., et al.. (2021). Solid-pseudopapilläre Neoplasien des Pankreas. Der Chirurg. 93(1). 72–81.
12.
Prieske, Katharina, Malik Alawi, Anna Jaeger, et al.. (2021). Transcriptome Analysis in Vulvar Squamous Cell Cancer. Cancers. 13(24). 6372–6372. 4 indexed citations
13.
Weidemann, Sören, Natalia Gorbokon, Doris Höflmayer, et al.. (2021). Abstract 2833: Mesothelin expression in human tumor types: a tissue microarray study on more than 13,000 tumor samples. Cancer Research. 81(13_Supplement). 2833–2833. 1 indexed citations
14.
Dum, David, Niclas C. Blessin, Tim Mandelkow, et al.. (2021). Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence. American Journal of Clinical Pathology. 156(Supplement_1). S137–S138. 1 indexed citations
15.
Eichenauer, Till, Christoph Fraune, Tim Mandelkow, et al.. (2020). High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma. World Journal of Urology. 39(2). 481–490. 10 indexed citations
16.
Blessin, Niclas C., Ronald Simon, Martina Kluth, et al.. (2018). Abstract 696: Patterns of TIGIT expression in normal lymphatic tissue, inflammation and cancer. Cancer Research. 78(13_Supplement). 696–696.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Farrington Breakdown of academic impact, for papers by Taweevat Attaseth Breakdown of academic impact, for papers by Jaya Thomas Breakdown of academic impact, for papers by Ani K. Stoyanova Breakdown of academic impact, for papers by Katsushige Kawase Breakdown of academic impact, for papers by Nelusha Amaladas Breakdown of academic impact, for papers by Yuxin Huang Breakdown of academic impact, for papers by Maryam Bourhaba Breakdown of academic impact, for papers by Xinru Lim
Rankless by CCL
2026